Y Intercept (Hong Kong) LTD Exact Sciences Corp Transaction History

Y Intercept (Hong Kong) LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$56.27 - $73.77 $27,234 - $35,704	-484 Reduced 7.01%	6,422 $443,000
Q4 2023 Feb 13, 2024	BUY	$59.06 - $75.72 $104,063 - $133,418	1,762 Added 34.25%	6,906 $510,000
Q3 2023 Nov 14, 2023	SELL	$65.94 - $99.04 $390,958 - $587,208	-5,929 Reduced 53.54%	5,144 $350,000
Q2 2023 Aug 14, 2023	SELL	$62.68 - $95.05 $109,940 - $166,717	-1,754 Reduced 13.67%	11,073 $1.04 Million
Q1 2023 May 09, 2023	SELL	$47.19 - $70.77 $184,748 - $277,064	-3,915 Reduced 23.38%	12,827 $869,000
Q4 2022 Feb 14, 2023	BUY	$30.35 - $53.15 $508,119 - $889,837	16,742 New	16,742 $828,000

676

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.2B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Y Intercept (Hong Kong) LTD, based on Form 13F filings with the SEC.

Stay updated on Y Intercept (Hong Kong) LTD with notifications on news.